Immunoclin Corp Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Immunoclin Corp had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $266.68 thousand as of 2013-11-30, per its 10-Q filed 2014-01-21.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-01-21
- 2013-11-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $266.68K.
- 2013-08-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $201.87K.
- 2013-05-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $135.93K.
- 2013-02-28: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $91.03K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2013-11-30 | $266.68K 10-Q · filed 2014-01-21 | |
| 2013-08-31 | $201.87K 10-Q · filed 2013-10-21 | |
| 2013-05-31 | $135.93K 10-Q · filed 2013-07-22 | |
| 2013-02-28 | $91.03K 10-Q · filed 2014-01-21 | |
| 2012-11-30 | -$85.44K 10-Q · filed 2013-01-22 | |
| 2012-08-31 | -$79.74K 10-Q/A · filed 2012-10-22 | |
| 2012-05-31 | -$106.96K 10-Q · filed 2012-07-16 | |
| 2012-02-29 | $90.70K 10-K · filed 2013-06-13 | -$90.70K 10-K · filed 2012-06-12 |
| 2011-02-28 | -$6.00K 10-K · filed 2012-06-12 |